The Critical Care Pharmacy Preparatory Review Course will be held Saturday and Sunday, April 25-26, 2020.

Click below for the full meeting schedule.

ACCP Spring Forum Preparatory
Review and Recertification Courses
April 25-26, 2020

Critical Care Pharmacy Preparatory Review and Recertification Course -- Neurocritical Care, Acute Cardiac Care, and Cardiovascular Critical Care

Sunday, April 28, 2019 from 8:00 AM to 11:30 AM CDT at Academic and Research Building: First Floor, Room 111

Available for 3.25 hours of CPE credit
Activity Number: 0217-0000-19-072-L01-P

Neurocritical Care
8:00 AM to 9:30 AM
Academic and Research Building: First Floor, Room 111

Speaker: Aaron Cook, Pharm.D., BCPS, BCCCP
Clinical Coordinator Neuroscience-Pulmonary/Critical Care, Assistant Adjunct Professor, Pharmacy at the University of Kentucky Lexington, Kentucky
View Biography
Aaron  Cook, Pharm.D., BCPS, BCCCP

Learning Objectives
1. Identify pertinent pathophysiological and laboratory changes that acutely occur after neurological injuries and require therapeutic intervention.
2. Describe monitoring devices commonly used in neurocritical care patients that help with developing and optimizing treatment strategies.
3. Develop an evidence-based treatment strategy for neurocritical care patients that will optimize patient outcomes and reduce the risk of adverse drug effects and drug interactions.
4. Recommend a monitoring plan to assess response to therapeutic regimens and specific therapeutic goals for neurocritical care patients.
5. Reassess and develop new plans of care for neurocritical care patients according to therapeutic and adverse outcomes and progress toward therapeutic goals.
9:30 AM to 9:40 AM
Acute Cardiac Care
9:40 AM to 10:30 AM
Academic and Research Building: First Floor, Room 111

Faculty: Scott T. Benken, Pharm.D., BCPS-AQ Cardiology
Clinical Pharmacist, Medical ICU, University of Illinois Hospital & Health Sciences System, Chicago, Illinois
View Biography
Scott T. Benken, Pharm.D., BCPS-AQ Cardiology
Speaker: Stephanie Dwyer, PharmD
Cardiovascular Clinical Pharmacist, University of Illinois Hospital and Health Sciences System Clinical Assistant Professor, University of Illinois at Chicago College of Pharmacy
View Biography
Stephanie Dwyer, PharmD

Learning Objectives
1. Manage cardiac arrest from the initiation of basic life support to the use of post–cardiac arrest care.
2. Categorize the indications and contraindications for medication administration during cardiac arrest.
3. Illustrate the utility of therapeutic hypothermia and the patient groups to which it should be applied.
4. Predict the common complications of therapeutic hypothermia and explain how to ameliorate them.
5. Contrast the different presentations of hypertensive emergency.
6. Analyze the therapeutic goals and clinical indi¬cations for the medications used in hypertensive emergencies.
Cardiovascular Critical Care
10:30 AM to 11:30 AM
Academic and Research Building: First Floor, Room 111

Faculty: James C. Coons, Pharm.D., FCCP, BCCP
Associate Professor, Department of Pharmacy and Therapeutics University of Pittsburgh School of Pharmacy Clinical Pharmacist, Cardiology UPMC Presbyterian Hospital
View Biography
James C. Coons, Pharm.D., FCCP, BCCP

Learning Objectives
1. Interpret a patient’s hemodynamic status accounting for cardiovascular anatomy, inherent physiologic function, and circulation, and recommend appropriate corresponding pharmacotherapeutic regimens.
2. Evaluate patients, and devise a treatment strategy for patients with cardiogenic shock, considering pharmacodynamic response to vasopressors/inotro¬pes.
3. Evaluate and interpret the contributing effects of various cardiovascular disease states associated with cardiogenic shock.
4. Recommend appropriate pharmacotherapeutic regimens in cardiovascular diseases in critically ill patients, including, but not limited to, cardiogenic shock, coronary artery disease, heart failure, val¬vular disease, and cardiac surgery perioperative management.
5. Recognize the options for and roles of mechanical circulatory support and heart transplantation as advanced therapies for heart failure and/or cardiogenic shock.